Old Web
English
Sign In
Acemap
>
Paper
>
Immunotherapy-refractory, EGFR overexpressing metastatic porocarcinoma responding to cetuximab
Immunotherapy-refractory, EGFR overexpressing metastatic porocarcinoma responding to cetuximab
2021
Francesca Comito
Maria C. Nigro
Francesca Sperandi
Barbara Melotti
Andrea Ardizzoni
Keywords:
Immunotherapy
Medicine
Refractory
Cancer research
Cetuximab
Text mining
Correction
Source
Cite
Save
Machine Reading By IdeaReader
8
References
0
Citations
NaN
KQI
[]